Somapacitan

ATC H01AC07 · 10 markets · 28 records

Somapacitan 10 markets · 28 records Forms

AU 6 records · 6 strengths

  • 15 mg/1.5 mLinjectionSOGROYA also in SG·TW·GB
  • 10 mg/1.5 mLinjectionSOGROYA also in SG·TW·GB
  • 10 mg/mLinjectionSOGROYA somapacitan 10 mg (6.7 mg/mL) solution for injection prefilled pen unknown
  • 6.7 mg/mLinjectionSOGROYA somapacitan 10 mg (6.7 mg/mL) solution for injection prefilled pen unknown
  • 3.3 mg/mLinjectionSOGROYA somapacitan 10 mg (6.7 mg/mL) solution for injection prefilled pen unknown

Records without a stated strength · 1 SOGROYA

US 3 records · 3 strengths

CA 3 records · 3 strengths

SG 3 records · 3 strengths

TW 3 records · 3 strengths

HK 3 records · 1 strengths

    Records without a stated strength · 1 SOGROYA SOLUTION FOR INJECTION IN PRE-FILLED PEN 5MG/1.5ML

    GB 2 records · 2 strengths

    MX 1 records · 1 strengths

      Records without a stated strength · 1 SOGROYA

      EU 1 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        Records without a stated strength · 1 SOGROYA

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

        A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.